Evidence map›Paper›PMID 37786899›Full record

ArticleMicrosystems & nanoengineering2023

Enhanced YOLOv5 network-based object detection (BALFilter Reader) promotes PERFECT filter-enabled liquid biopsy of lung cancer from bronchoalveolar lavage fluid (BALF).

Zheng Liu, Jixin Zhang, Ningyu Wang, Yun'ai Feng, Fei Tang, Tingyu Li, Liping Lv, Haichao Li, Wei Wang, Yaoping Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microsystems & nanoengineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Zheng Liu *School of Software and Microelectronics, Peking University, Beijing, 100871 China.
Jixin Zhang *Department of Pathology, Peking University First Hospital, Beijing, 100034 China.
Ningyu Wang *School of Integrated Circuits, Peking University, Beijing, 100871 China.
Yun'ai FengDepartment of Respirology and Critical Care Medicine, Peking University First Hospital, Beijing, 100034 China.
Fei TangDepartment of Interventional Lung Disease and Center of Endoscopic Diagnosis and Treatment, Anhui Chest Hospital, Hefei, Anhui 230022 China.
Tingyu LiSchool of Integrated Circuits, Peking University, Beijing, 100871 China.
Liping LvDepartment of Interventional Lung Disease and Center of Endoscopic Diagnosis and Treatment, Anhui Chest Hospital, Hefei, Anhui 230022 China.
Haichao LiDepartment of Respirology and Critical Care Medicine, Peking University First Hospital, Beijing, 100034 China.
Wei WangSchool of Integrated Circuits, Peking University, Beijing, 100871 China.ORCID 0000-0002-5257-7675
Yaoping LiuSchool of Integrated Circuits, Peking University, Beijing, 100871 China.ORCID 0000-0002-1194-0976
Peking University · CNAnhui Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liquid biopsy of cancers, detecting tumor-related information from liquid samples, has attracted wide attentions as an emerging technology. Our previously reported large-area PERFECT (

Indexed as

Electrical and electronic engineeringNanoscience and technology

Identifiers

PMID37786899
PMCPMC10541878
OpenAlexW4387185856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.